IOL Chemicals hits record Q4 revenue of ₹619.5 cr, PAT up 68%
Strong momentum in Pharma and Chemicals drives best-ever quarterly performance; ₹164 cr capex announced.
— 1 earlier story on IOL Chemicals And Pharmaceuticals Ltd. →What's new
- Record Q4 revenue of ₹619.5 cr
- PAT surges 68.2% to ₹53.2 cr
- ₹164 cr capex for expansion and automation
Why it matters
These are exceptional numbers, but the core financials were already disclosed. What changes here is the detail on segment momentum and a confirmed ₹164 crore capex cycle. The open question is whether this pace can be sustained into FY27.
What we're watching
- Sustainability of Pharma and Chemicals growth into FY27
- Execution of ₹164 cr capex plan
- Any margin pressure from raw materials
The full read
IOL Chemicals posted its best quarter ever in Q4 FY26, with revenue of ₹619.5 crore and PAT up 68.2% to ₹53.2 crore. The company said both Pharma and Chemicals segments drove the growth. It also disclosed a ₹164 crore capex programme for capacity expansion and automation, funded through internal accruals. However, this press release is a detailed reiteration of numbers already shared in the audited results. The quarter is strong, but the market has seen the headline figures. What investors gain here is colour on segmental strength and capex specifics, not new surprises.